Non‑Zaire Ebola Strain Detected in DRC Outbreak as Cases Reach 246

Cases are concentrated in the Mongwalu and Rwampara health zones.

This marks the 17th outbreak in the country since 1976.

Preliminary genetic sequencing suggests the virus is not the Zaire strain, which has driven nearly all previous DRC outbreaks.

Further sequencing is underway to identify the exact subtype.

Jean‑Jacques Muyembe said that identifying a non‑Zaire Ebola strain could complicate the response because existing vaccines and treatments target the Zaire strain.

Uganda reported one imported confirmed Ebola case in Kampala.

Early reports from Uganda indicate the imported case involved the Bundibugyo strain, one of the three Ebola species besides Zaire that have caused large outbreaks.

Vaccines such as rVSV‑ZEBOV and monoclonal antibody regimens were evaluated in a cluster randomized trial during the 2018‑2020 DRC outbreak, enrolling over 4,000 contacts and showing high efficacy against Zaire Ebola.

No comparable efficacy data exist yet for Bundibugyo or other non‑Zaire strains.

Health workers should maintain strict infection‑control measures, and authorities may need to consider investigational therapeutics that show broader filovirus activity.

Public messaging should emphasize early reporting of fever and avoidance of contact with bodily fluids.

What to watch next: Results of ongoing genetic sequencing to confirm the strain, any early data on vaccine or therapeutic performance against it, and the trajectory of case numbers in both DRC and Uganda.